27. Rodan, G.A. and T.J. Martin, Role of osteoblasts in hormonal control of boneresorption--a hypothesis. Calcif Tissue Int, 1981. 33(4): p. 349-51.28. Vaananen, K., Osteoclast function: bone biology and mechanisms. , in Principlesof Bone Biology, J.R. Bilezikian, LG. Rodan, GA., Editor. 1996, New York:Academic. p. 103-13.29. Parfitt, A.M., Quantum concept of bone remodeling and turnover: implications forthe pathogenesis of osteoporosis. Calcif Tissue Int, 1979. 28(1): p. 1-5.30. Parfitt, A.M., The mechanism of coupling: a role for the vasculature. Bone, 2000.26(4): p. 319-23.31. Caillot-Augusseau, A., et al., Bone formation and resorption biological markers incosmonauts during and after a 180-day space flight (Euromir 95). Clin Chem,1998. 44(3): p. 578-85.32. Sato, Y., et al., Accelerated bone remodeling in patients with poststrokehemiplegia. J Stroke Cerebrovasc Dis, 1998. 7(1): p. 58-62.33. Maimoun, L., et al., Use of bone biochemical markers with dual-energy x-rayabsorptiometry for early determination of bone loss in persons with spinal cordinjury. Metabolism, 2002. 51(8): p. 958-63.34. Donahue, S.W., et al., Parathyroid hormone may maintain bone formation inhibernating black bears (Ursus americanus) to prevent disuse osteoporosis. JExp Biol, 2006. 209(Pt 9): p. 1630-8.35. Floyd, T., R.A. Nelson, and G.F. Wynne, Calcium and bone metabolichomeostasis in active and denning black bears (Ursus americanus). Clin OrthopRelat Res, 1990(255): p. 301-9.36. Pace, N., et al., Effect of 14 days of bed rest on urine metabolite excretion andplasma enzyme levels. Life Sci Space Res, 1975. 13: p. 41-7.37. Manolagas, S.C., Choreography from the tomb: An emerging role of dyingosteocytes in the purposeful, and perhaps not so purposeful, targeting of boneremodeling. BoneKEy-Osteovision, 2006. 3(1): p. 5-14.38. Burger, E.H., J. Klein-Nulend, and T.H. Smit, Strain-derived canalicular fluid flowregulates osteoclast activity in a remodelling osteon--a proposal. J Biomech,2003. 36(10): p. 1453-9.39. Kogianni, G., V. Mann, and B.S. Noble, Apoptotic bodies convey activity capableof initiating osteoclastogenesis and localized bone destruction. J Bone MinerRes, 2008. 23(6): p. 915-27.40. Heino, T.J., et al., Evidence for the role of osteocytes in the initiation of targetedremodeling. Technol Health Care, 2009. 17(1): p. 49-56.138
41. Chowdhury, I., B. Tharakan, and G.K. Bhat, Current concepts in apoptosis: Thephysiological suicide program revisited. Cell Mol Biol Lett, 2006. 11(4): p. 506-25.42. Pagliari, L.J., et al., The multidomain proapoptotic molecules Bax and Bak aredirectly activated by heat. Proc Natl Acad Sci U S A, 2005. 102(50): p. 17975-80.43. Oltvai, Z.N., C.L. Milliman, and S.J. Korsmeyer, Bcl-2 heterodimerizes in vivowith a conserved homolog, Bax, that accelerates programmed cell death. Cell,1993. 74(4): p. 609-19.44. Burlacu, A., Regulation of apoptosis by Bcl-2 family proteins. J Cell Mol Med,2003. 7(3): p. 249-57.45. Fleck, C.C. and H.V. Carey, Modulation of apoptotic pathways in intestinalmucosa during hibernation. Am J Physiol Regul Integr Comp Physiol, 2005.289(2): p. R586-R595.46. Lesauskaite, V., et al., Apoptosis of cardiomyocytes in explanted andtransplanted hearts. Comparison of results from in situ TUNEL, ISEL, and ISOLreactions. Am J Clin Pathol, 2004. 121(1): p. 108-16.47. Hedgecock, N.L., et al., Quantitative regional associations between remodeling,modeling, and osteocyte apoptosis and density in rabbit tibial midshafts. Bone,2007. 40(3): p. 627-37.48. Aguirre, J.I., et al., Osteocyte apoptosis is induced by weightlessness in miceand precedes osteoclast recruitment and bone loss. J Bone Miner Res, 2006.21(4): p. 605-15.49. Bellido, T., et al., Proteasomal degradation of Runx2 shortens parathyroidhormone-induced anti-apoptotic signaling in osteoblasts. A putative explanationfor why intermittent administration is needed for bone anabolism. J Biol Chem,2003. 278(50): p. 50259-72.50. Basso, N. and J.N. Heersche, Effects of hind limb unloading and reloading onnitric oxide synthase expression and apoptosis of osteocytes and chondrocytes.Bone, 2006. 39(4): p. 807-14.51. Basso, N., et al., The effect of reloading on bone volume, osteoblast number, andosteoprogenitor characteristics: studies in hind limb unloaded rats. Bone, 2005.37(3): p. 370-8.52. Ishijima, M., et al., Osteopontin is associated with nuclear factor kappaB geneexpression during tail-suspension-induced bone loss. Exp Cell Res, 2006.312(16): p. 3075-83.53. Sakai, A., et al., Disruption of the p53 gene results in preserved trabecular bonemass and bone formation after mechanical unloading. J Bone Miner Res, 2002.17(1): p. 119-27.139
- Page 1 and 2:
EXPLORATION OF THE ROLE OF SERUM FA
- Page 3 and 4:
Table of contentsIndex of Figures .
- Page 5 and 6:
Chapter Four - Attempts to find an
- Page 7 and 8:
Index of figures1.1. Simplified sch
- Page 9 and 10:
6.17. Longitudinal analysis of OPG
- Page 11 and 12:
6.49. Longitudinal analysis of ColI
- Page 13 and 14:
A.2. Complete list of BSALP correla
- Page 15 and 16:
List of abbreviationsα-MEM. Alpha-
- Page 17 and 18:
PCR. Polymerase chain reactionPer1
- Page 19 and 20:
G2/M checkpoint. The point in the c
- Page 21 and 22:
Species names13-lined ground squirr
- Page 23 and 24:
Chapter One - Background and signif
- Page 25 and 26:
1.3 Bone turnover is unbalanced dur
- Page 27 and 28:
pro-apoptosis regulator BAX. An imp
- Page 29 and 30:
low-dose administration of parathyr
- Page 31 and 32:
decrease in bone trabecular thickne
- Page 33 and 34:
experience periodic arousals in whi
- Page 35 and 36:
ears must have evolved a mechanism
- Page 37 and 38:
1.7.6 Hypothesis 2: OCN interacts w
- Page 39 and 40:
ain, heart, and femoral muscle of h
- Page 41 and 42:
Hypothesis 3a: Serum concentrations
- Page 44:
were released. Behavior indicating
- Page 47 and 48:
2.3 ResultsSerum activity of the bo
- Page 49 and 50:
(p
- Page 51 and 52:
post-hibernation sampling in the be
- Page 53 and 54:
also unclear whether ucOCN may affe
- Page 55 and 56:
atios of intact to fragmented OCN m
- Page 57 and 58:
Table 2.3—Bone marker “seasonal
- Page 59 and 60:
Table 2.7—Chemistry panel “seas
- Page 61 and 62:
ABNormalized BSALPBSALP (U/L)CO N D
- Page 63 and 64:
Total Calcium (mg/dL)A1.21.151.11.0
- Page 65 and 66:
ABTotal OCN (ng/mL)150100500O N D J
- Page 67 and 68:
Adiponectin (ng/mL)AB40003500300025
- Page 69 and 70:
ABNormalized InsulinInsulin (μU/mL
- Page 71 and 72:
surrounding and encompassing hibern
- Page 73 and 74:
decreased from 788+30 ng/mL in preh
- Page 75 and 76:
120-122]. Most small hibernators ar
- Page 77 and 78:
ears. Similarly, serum NPY increase
- Page 79 and 80:
Table 3.2—Serum factor longitudin
- Page 81 and 82:
Leptin (ng/mL)ABO N D J F M A M O N
- Page 83 and 84:
Norepinephrine (ng/mL)A807060504030
- Page 85 and 86:
IGF‐1 (ng/mL)AN D J F M A MB10009
- Page 87 and 88:
2008. Samples were collected as des
- Page 89 and 90:
sampling points. It is possible to
- Page 91 and 92:
C‐Terminal PTH (Relative)AB504030
- Page 93 and 94:
Chapter Five — Serum from hiberna
- Page 95 and 96:
Synergy HT Multi-Detection Micropla
- Page 97 and 98:
gene specific primers and 12.5 μL
- Page 99 and 100:
involved in the reduced caspase-3/7
- Page 101 and 102:
hibernation cycles without problem
- Page 103 and 104:
filtered seasonal bear serum and fo
- Page 105 and 106:
which is dependent upon caspase-3 a
- Page 107 and 108:
Caspase‐3/7 ActivityO N D J F M A
- Page 109 and 110: 6Caspase‐3/7 Activity54321**0Vehi
- Page 111 and 112: ABCaspase‐3/7 Activity9876543210*
- Page 113 and 114: eyond the G1/S checkpoint, thus ind
- Page 115 and 116: ears, it is possible that tissue se
- Page 117 and 118: PTH1R, RANKL, Runx2, Smurf1, TLR4,
- Page 119 and 120: factors Runx2 and OCN also increase
- Page 121 and 122: Table 6.3—Gene expression 3 hour
- Page 123 and 124: Table 6.5—Gene expression 6 day d
- Page 125 and 126: Cyclin D1 Gene ExpressionO N D J F
- Page 127 and 128: Smurf1 Gene ExpressionO N D J F M A
- Page 129 and 130: BAK Gene ExpressionO N D J F M A MM
- Page 131 and 132: M‐CSF Gene ExpressionO N D J F M
- Page 133 and 134: Per1 Gene ExpressionO N D J F M A M
- Page 135 and 136: Akt Gene ExpressionO N D J F M A MM
- Page 137 and 138: Bcl‐2 Gene ExpressionO N D J F M
- Page 139 and 140: Cyclin D1 Gene ExpressionO N D J F
- Page 141 and 142: OPN Gene ExpressionO N D J F M A MM
- Page 143 and 144: 2PTH1R Gene Expression1.510.50O N D
- Page 145 and 146: TLR4 Gene ExpressionO N D J F M A M
- Page 147 and 148: Bcl‐2 Gene ExpressionO N D J F M
- Page 149 and 150: OCN Gene ExpressionO N D J F M A MM
- Page 151 and 152: PTH1R Gene ExpressionO N D J F M A
- Page 153 and 154: TLR4 Gene ExpressionO N D J F M A M
- Page 155 and 156: condition in renal patients in whic
- Page 157 and 158: hibernation. This report brings to
- Page 159: 14. Kaneps, A.J., S.M. Stover, and
- Page 163 and 164: 68. Ashe, M.C., et al., Bone geomet
- Page 165 and 166: 95. Perrien, D.S., et al., Aging al
- Page 167 and 168: 122. Lesser, R.W., et al., Renal re
- Page 169 and 170: 151. Confavreux, C.B., R.L. Levine,
- Page 171 and 172: 178. Toribara, T.Y., A.R. Terepka,
- Page 173 and 174: 206. Luo, X.H., et al., Adiponectin
- Page 175 and 176: 233. Florant, G.L., et al., Fat-cel
- Page 177 and 178: 259. Bhasin, S., et al., Older men
- Page 179 and 180: 284. Miura, M., et al., A crucial r
- Page 181 and 182: Appendix A—Complete tables of cor
- Page 183 and 184: Table A.5—Complete list of ionize
- Page 185 and 186: Table A.7—Complete list of adipon
- Page 187 and 188: Table A.12—Complete list of norep